STAT Plus: Sanofi MS drug reduced brain lesions in preliminary study
KRISTOFFER TRIPPLAAR/SIPA VIA AP IMAGES
Sanofi had planned to unveil the results at a medical meeting, but is instead making its own data presentation because of the impact of Covid-19.


No hay comentarios:
Publicar un comentario